SEARCH

SEARCH BY CITATION

REFERENCES

  • Aronson KJ, Miller AB, Woolcott CG, Sterns EE, McCready DR, Lickley LA, Fish EB, Hiraki GY, Holloway C, Ross T, Hanna WM, SenGupta SK, Weber JP. 2000. Breast adipose tissue concentrations of polychlorinated biphenyls and other organochlorines and breast cancer risk. Cancer Epidemiol Biomarkers Prev 9: 5563.
  • Bissery MC, Guenard D, Gueritte-Voegelein F, Lavelle F. 1991. Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue. Cancer Res 51: 48454852.
  • Boyle P. 2000. Untitled presentation. European Breast Cancer Conference, October 28, 2000.
  • Coogan PF, Rosenberg L, Shapiro S, Hoffman M. 1999. Lactation and breast carcinoma risk in a South African population. Cancer 86: 982989.
  • Cummings SR, Eckert S, Krueger KA, Grady D, Powles TJ, Cauley JA, Norton L, Nickelsen T, Bjarnason NH, Morrow M, Lippman ME, Black D, Glusman JE, Costa A, Jordan VC. 1999. The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation. JAMA 281: 21892197.
  • Dooley WC, Veronesi U, Elledge R, O'Shaughnessy J, Ljung B, Arias R. 2001. Detection of premalignant and malignant breast cells by ductal lavage. Obstet Gynecol 97(Suppl 1): S2.
  • Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieand S, Tan-Chiu E, Ford L, Wolmark N. 1998. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90: 13711388.
  • Gallo JJ, Armenian HK, Ford DE, Eaton WW, Khachaturian AS. 2000. Major depression and cancer: the 13-year follow-up of the Baltimore epidemiologic catchment area sample (United States). Cancer Causes Control 11: 751758.
  • Gandini S, Merzenich H, Robertson C, Boyle P. 2000. Meta-analysis of studies on breast cancer risk and diet: the role of fruit and vegetable consumption and the intake of associated micronutrients. Eur J Cancer 36: 636646.
  • Grabrick DM, Hartmann LC, Cerhan JR, Vierkant RA, Therneau TM, Vachon CM, Olson JE, Couch FJ, Anderson KE, Pankratz VS, Sellers TA. 2000. Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer. JAMA 284: 17911798.
  • Hansen J. 2001. Increased breast cancer risk among women who work predominantly at night. Epidemiology 12: 7477.
  • Harris AL, Zhang H, Moghaddam A, Fox S, Scott P, Pattison A, Gatter K, Stratford I, Bicknell R. 1996. Breast cancer angiogenesis: new approaches to therapy via antiangiogenesis, hypoxic activated drugs, and vascular targeting. Breast Cancer Res Treat 38: 97108.
  • Hjartåker A, Laake P, Lund E. 2001. Childhood and adult milk consumption and risk of premenopausal breast cancer in a cohort of 48,844 women—the Norwegian women and cancer study. Int J Cancer 93: 888893.
  • Holmes MD, Hunter DJ, Colditz GA, Stampfer MJ, Hankinson SE, Speizer FE, Rosner B, Willett WC. 1999. Association of dietary intake of fat and fatty acids with risk of breast cancer. JAMA 281: 914920.
  • Jasienska G, Thune I. 2001. Lifestyle, hormones, and risk of breast cancer. Br Med J 322: 586587.
  • Johnson KC, Hu J, Mao Y. 2000. Passive and active smoking and breast cancer risk in Canada, 1994–97. The Canadian Cancer Registries Epidemiology Research Group. Cancer Causes Control 11: 211221.
  • Key TJ, Sharp GB, Appleby PN, Beral V, Goodman MT, Soda M, Mabuchi K. 1999. Soya foods and breast cancer risk: a prospective study in Hiroshima and Nagasaki, Japan. Br J Cancer 81: 12481256.
  • Lemonick MD, Park A. 2001. New hope for cancer. Time May 28: 6269.
  • Li CI, Weiss NS, Stanford JL, Daling JR. 2000. Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women. Cancer 88: 25702577.
  • McNeil C. 1998. Herceptin raises its sights beyond advanced breast cancer. J Natl Cancer Inst 90: 882883.
  • Melbye M, Wohlfahrt J, Lei U, Norgaard-Pedersen B, Mouridsen HT, Lambe M, Michels KB. 2000. Alpha-fetoprotein levels in maternal serum during pregnancy and maternal breast cancer incidence. J Natl Cancer Inst 92: 10011005.
  • Murray JL, Przepiorka D, Ioannides CG. 2000. Clinical trials of HER-2/neu-specific vaccines. Semin Oncol 27(Suppl 11): 7175.
  • O'Meara ES, Rossing MA, Daling JR, Elmore JG, Barlow WE, Weiss NS. 2001. Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality. J Natl Cancer Inst 93: 754762.
  • Pisano ED, Kuzmiak C, Koomen M, Cance W. 2001. What every surgical oncologist should know about digital mammography. Semin Surg Oncol 20: 181186.
  • Plourde PV, Dyroff M, Dukes M. 1994. Arimidex: a potent and selective fourth-generation aromatase inhibitor. Breast Cancer Res Treat 30: 103111.
  • Pollan M, Gustavsson P. 1999. High-risk occupations for breast cancer in the Swedish female working population. Am J Public Health 89: 875881.
  • Schairer C, Lubin J, Troisi R, Sturgeon S, Brinton L, Hoover R. 2000. Estrogen-progestin replacement and risk of breast cancer. JAMA 284: 691694.
  • Slichenmyer WJ, Von Hoff DD. 1991. Taxol: a new and effective anti-cancer drug. Anticancer Drugs 2: 519530.
  • Stevens RG, Rea MS. 2001. Light in the built environment: potential role of circadian disruption in endocrine disruption and breast cancer. Cancer Causes Control 12: 279287.
  • Stewart TH, Sage RD, Stewart AF, Cameron DW. 2000. Breast cancer incidence highest in the range of one species of house mouse, Mus domesticus. Br J Cancer 82: 446451.
  • Toniolo P, Van Kappel AL, Akhmedkhanov A, Ferrari P, Kato I, Shore RE, Riboli E. 2001. Serum carotenoids and breast cancer. Am J Epidemiol 153: 11421147.
  • van den Brandt PA, Spiegelman D, Yaun SS, Adami HO, Beeson L, Folsom AR, Fraser G, Goldbohm RA, Graham S, Kushi L, Marshall JR, Miller AB, Rohan T, Smith-Warner SA, Speizer FE, Willett WC, Wolk A, Hunter DJ. 2000. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 152: 514527.
  • Verkasalo PK, Pukkala E, Stevens RG, Ojamo M, Rudanko SL. 1999. Inverse association between breast cancer incidence and degree of visual impairment in Finland. Br J Cancer 80: 14591460.
  • Verkasalo PK, Thomas HV, Appleby PN, Davey GK, Key TJ. 2001. Circulating levels of sex hormones and their relation to risk factors for breast cancer: a cross-sectional study in 1092 pre- and postmenopausal women (United Kingdom). Cancer Causes Control 12: 4759.
  • Whiteman MK, Cui Y, Flaws JA, Langenberg P, Bush TL. 2001. Media coverage of women's health issues: is there a bias in the reporting of an association between hormone replacement therapy and breast cancer? J Womens Health Gend Based Med 10: 571577.
  • Wu AH, Pike MC, Stram DO. 1999. Meta-analysis: dietary fat intake, serum estrogen levels, and the risk of breast cancer. J Natl Cancer Inst 91: 529534.
  • Zheng W, Gustafson DR, Sinha R, Cerhan JR, Moore D, Hong CP, Anderson KE, Kushi LH, Sellers TA, Folsom AR. 1998. Well-done meat intake and the risk of breast cancer. J Natl Cancer Inst 90: 17241729.